Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Attenuated Levels of Surface TREM1 on Circulating Neutrophils Predict Poor Survival in Patients with Diffuse Large B-Cell Lymphoma before Treatment

Hao-Yuan Wang, Po-Chun Liu, Fu-Chen Yang, Yi-Ting Chen, Ching-Fen Yang, Chun-Kuang Tsai, Po-Shen Ko, Yao-Chung Liu, Nien-Jung Chen

Blood (2024) 144 (Supplement 1): 6273.

https://doi.org/10.1182/blood-2024-198810

Published: 2024

Journal Articles

Long-Term Real-World Follow-up Study of Luspatercept for Lower-Risk Myelodysplastic Neoplasms

Zhuxin Zhang, Leyu Wang, Ziwei Liu, Chen Yang, Miao Chen, Bing Han, Junling Zhuang

Blood (2024) 144 (Supplement 1): 6730.

https://doi.org/10.1182/blood-2024-199403

Published: 2024

Journal Articles

Effective Treatment of Refractory Aplastic Anemia with Romiplostim after Failure of Multiple Thrombopoietin Receptor Agonists: A Single-Center Retrospective Study

Xijuan Lin, Chen Yang, Ziwei Liu, Junling Zhuang, Miao Chen, Bing Han

Blood (2024) 144 (Supplement 1): 4077.

https://doi.org/10.1182/blood-2024-200421

Published: 2024

Journal Articles

KP104, a Bifunctional C5 Mab-Factor H Fusion Protein, Demonstrates Sustained Long-Term Efficacy and Safety in Complement Inhibitor-Naïve PNH Patients: Updated Results from a Phase 2 Study at 36/38 Weeks of Obd Treatment

Fengkui Zhang, Li Zhang, Chen Yang, Changhe Yue, Jay Ma, Chaomei He, Ping Tsui, Qing Yu Christina Weng, Helen Fu, Hui Yan, Wenru Song, Bing Han

Blood (2024) 144 (Supplement 1): 2699.

https://doi.org/10.1182/blood-2024-210086

Published: 2024

Journal Articles

A Phase I First-in-Human, Open-Label Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0500, a Humanized GPRC5D-BCMA-CD3 Trispecific Antibody, in Participants with Relapsed or Refractory Multiple Myeloma

Yan Xu, Zhen Cai, Zhongjun Xia, Chen Yang, Jia Chen, Zewen Zhu, Xiaojuan Jing, Ji Tian, Nating Zhang, Ailing Cui, Jianxing Tang, Haolin Sun, Lugui Qiu

Blood (2024) 144 (Supplement 1): 3381.2.

https://doi.org/10.1182/blood-2024-200737

Published: 2024

Journal Articles

Rituximab Plus Bortezomib for Refractory and Relapsed Warm Autoimmune Hemolytic Anemia：a Prospective, Single-Arm, Phase Ⅱ Trial

Xijuan Lin, Chen Yang, Junling Zhuang, Daobin Zhou, Miao Chen, Bing Han

Blood (2023) 142 (Supplement 1): 3829.

https://doi.org/10.1182/blood-2023-178625

Published: 2023

Journal Articles

Transcriptomic Profile of Peripheral Blood Mononuclear Cells in Sirolimus-Sensitive Acquired Pure Red Cell Aplasia Patients

Yuan Yang, Qinglin Hu, Chen Yang, Miao Chen, Junling Zhuang, Bing Han

Blood (2023) 142 (Supplement 1): 5199.

https://doi.org/10.1182/blood-2023-179897

Published: 2023

Journal Articles

KP104, a Bifunctional C5 Antibody/Factor H Fusion Protein, Effectively Controls Both Intravascular and Extravascular Hemolysis: Interim Results from a Phase 2 Study in Complement Inhibitor-Naïve PNH Patients

Fengkui Zhang, Li Zhang, Chen Yang, Chunrong Wang, Changhe Yue, Hui Yan, Jay Ma, Helen Fu, Chaomei He, Ping Tsui, Jingtao Wu, Richard Lee, Wenru Song, Bing Han

Blood (2023) 142 (Supplement 1): 572.

https://doi.org/10.1182/blood-2023-186453

Published: 2023

Journal Articles

Ratio of Circulating CD8 + T Lymphocytes to M-MDSCs (CD8MMR): A Novel Prognostic Predictor for Treatment-Naïve DLBCL Patients

Hao-Yuan Wang, Fu-Chen Yang, Ching-Fen Yang, Chun-Kuang Tsai, Po-Shen Ko, Yao-Chung Liu, Nien-Jung Chen

Blood (2023) 142 (Supplement 1): 1763.

https://doi.org/10.1182/blood-2023-178327

Published: 2023

Journal Articles

The Change of Complement Deposition after Complement Inhibitor Treatment in Paroxysmal Nocturnal Hemoglobinuria Patients

Menglu Zhang, Xuan Wang, Chen Yang, Miao Chen, Junling Zhuang, Bing Han

Blood (2023) 142 (Supplement 1): 1350.

https://doi.org/10.1182/blood-2023-178384

Published: 2023

Journal Articles

Myc Translocation Is an Adverse Factor Redefining High-Risk Multiple Myeloma

Xianghong Jin, Jianhua Du, Fujing Zhang, Hui Li, Shuangjiao Liu, Chen Yang, Miao Chen, Daobin Zhou, Junling Zhuang

Blood (2022) 140 (Supplement 1): 12575.

https://doi.org/10.1182/blood-2022-169332

Published: 2022

Journal Articles

Efficacy and Safety of Eltrombopag with or without Immunosuppressant in Patients with Relapsed/Refractory Acquired Aplastic Anemia: A Real-World Experience

Jiang Ji, Ziqi Wan, Jing Ruan, Yali Du, Miao Chen, Chen Yang, Zhao Wang, Bing Han

Blood (2021) 138 (Supplement 1): 1124.

https://doi.org/10.1182/blood-2021-145549

Published: 2021

Journal Articles

Higher Expression of TREM-2 on M-MDSC Cell Surface Independently Predicts Worse Survival in Adults with Newly-Diagnosed and Treatment-Naïve Non-Hodgkin Lymphoma

Hao-Yuan Wang, Fu-Chen Yang, Yao-Chung LIU, Po-Shen Ko, Ching-Fen Yang, Nien-Jung Chen

Blood (2021) 138 (Supplement 1): 1446.

https://doi.org/10.1182/blood-2021-153785

Published: 2021

Journal Articles

Plasma Lipidome Acts As Diagnostic Marker and Predictor for Cyclosporin Response in Patients with Aplastic Anemia

Jing Ruan, Bing Han, Zhao Wang, Chen Yang, Yali Du, Miao Chen

Blood (2021) 138 (Supplement 1): 2199.

https://doi.org/10.1182/blood-2021-145843

Published: 2021

Journal Articles

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

Congli Zhang, Xin-xin Cao, Dong-zhu Li, Jun Feng, MD, Lu Zhang, MD, Yan Zhang, Ming-hui Duan, MD, Miao Chen, MD, Chen Yang, Wei Wang, Dao-Bin Zhou, Jian Li, MD

Blood (2019) 134 (Supplement_1): 2127.

https://doi.org/10.1182/blood-2019-125505

Published: 2019

Journal Articles

Checkpoint Inhibitor PD-1H/VISTA Functions As MMP-13 Receptor on Osteoclasts and Mediates MMP-13 Induced Osteoclast Activation in Multiple Myeloma

Jing Fu, PhD, Shirong Li, PhD, Chen Yang, Lewis M Brown, PhD, Stephen J Weiss, MD PhD, Charles G Drake, MD PhD, Markus Y. Mapara, MD PhD, Suzanne Lentzsch, MD PhD

Blood (2019) 134 (Supplement_1): 3072.

https://doi.org/10.1182/blood-2019-129177

Published: 2019

Journal Articles

Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas

Jun Zhu, MD PhD, Junning Cao, MD, Lugui Qiu, MD PhD, Junyuan Qi, MD, Yuqin Song, MD PhD, Meifeng Tu, MD PhD, Dongmei Ji, MD PhD, Weina Shen, MD, Mingyuan Sun, MD, Ye Hua, MD, Chen Yang, MD, Chen Yu, MD, Jian Wang, PhD, Guangxiu Dai, PhD, Weiguo Su, PhD

Blood (2018) 132 (Supplement 1): 5324.

https://doi.org/10.1182/blood-2018-99-111648

Published: 2018

Journal Articles

Abnormalities of platelet aggregation associated with giant granules in a subset of platelets

Chen Yang, Ronald Jackups, Jr

Blood (2018) 131 (14): 1626.

https://doi.org/10.1182/blood-2017-12-821975

Published: 2018

Journal Articles

GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis

Philipp A. Dietrich, Chen Yang, Halina H. L. Leung, Jennifer R. Lynch, Estrella Gonzales, Bing Liu, Michelle Haber, Murray D. Norris, Jianlong Wang, Jenny Yingzi Wang

Blood (2014) 124 (22): 3284–3294.

https://doi.org/10.1182/blood-2013-10-532523

Published: 2014

Includes: Supplemental data

NARROW

Attenuated Levels of Surface TREM1 on Circulating Neutrophils Predict Poor Survival in Patients with Diffuse Large B-Cell Lymphoma before Treatment

Long-Term Real-World Follow-up Study of Luspatercept for Lower-Risk Myelodysplastic Neoplasms

Effective Treatment of Refractory Aplastic Anemia with Romiplostim after Failure of Multiple Thrombopoietin Receptor Agonists: A Single-Center Retrospective Study

KP104, a Bifunctional C5 Mab-Factor H Fusion Protein, Demonstrates Sustained Long-Term Efficacy and Safety in Complement Inhibitor-Naïve PNH Patients: Updated Results from a Phase 2 Study at 36/38 Weeks of Obd Treatment

A Phase I First-in-Human, Open-Label Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0500, a Humanized GPRC5D-BCMA-CD3 Trispecific Antibody, in Participants with Relapsed or Refractory Multiple Myeloma

Rituximab Plus Bortezomib for Refractory and Relapsed Warm Autoimmune Hemolytic Anemia：a Prospective, Single-Arm, Phase Ⅱ Trial

Transcriptomic Profile of Peripheral Blood Mononuclear Cells in Sirolimus-Sensitive Acquired Pure Red Cell Aplasia Patients

KP104, a Bifunctional C5 Antibody/Factor H Fusion Protein, Effectively Controls Both Intravascular and Extravascular Hemolysis: Interim Results from a Phase 2 Study in Complement Inhibitor-Naïve PNH Patients

Ratio of Circulating CD8 + T Lymphocytes to M-MDSCs (CD8MMR): A Novel Prognostic Predictor for Treatment-Naïve DLBCL Patients

The Change of Complement Deposition after Complement Inhibitor Treatment in Paroxysmal Nocturnal Hemoglobinuria Patients

Myc Translocation Is an Adverse Factor Redefining High-Risk Multiple Myeloma

Efficacy and Safety of Eltrombopag with or without Immunosuppressant in Patients with Relapsed/Refractory Acquired Aplastic Anemia: A Real-World Experience

Higher Expression of TREM-2 on M-MDSC Cell Surface Independently Predicts Worse Survival in Adults with Newly-Diagnosed and Treatment-Naïve Non-Hodgkin Lymphoma

Plasma Lipidome Acts As Diagnostic Marker and Predictor for Cyclosporin Response in Patients with Aplastic Anemia

Home Treatment of Bortezomib: A Preliminary Exploration of a New Treatment Mode in China

Checkpoint Inhibitor PD-1H/VISTA Functions As MMP-13 Receptor on Osteoclasts and Mediates MMP-13 Induced Osteoclast Activation in Multiple Myeloma

Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas

Abnormalities of platelet aggregation associated with giant granules in a subset of platelets

GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only